Total Payments
$1,595
2023 Payments
$158.68
Companies
22
Transactions
79
Medicare Patients
1,725
Medicare Billing
$150,556
Payment Breakdown by Category
Food & Beverage$1,550 (97.2%)
Education$44.96 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,550 | 76 | 97.2% |
| Education | $44.96 | 3 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $269.35 | 5 | $0 (2020) |
| Grifols USA, LLC | $214.68 | 4 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $150.64 | 13 | $0 (2018) |
| IDORSIA PHARMACEUTICALS US INC | $136.29 | 2 | $0 (2023) |
| GlaxoSmithKline, LLC. | $128.15 | 19 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $127.83 | 2 | $0 (2022) |
| UCB, Inc. | $106.11 | 5 | $0 (2018) |
| Resmed Corp | $73.89 | 1 | $0 (2017) |
| Gilead Sciences, Inc. | $63.64 | 5 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $52.55 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $158.68 | 3 | IDORSIA PHARMACEUTICALS US INC ($136.29) |
| 2022 | $160.91 | 4 | JAZZ PHARMACEUTICALS INC. ($115.18) |
| 2020 | $15.00 | 1 | AstraZeneca Pharmaceuticals LP ($15.00) |
| 2019 | $14.90 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14.90) |
| 2018 | $401.07 | 14 | AstraZeneca Pharmaceuticals LP ($239.96) |
| 2017 | $844.08 | 56 | Grifols USA, LLC ($214.68) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/26/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $120.65 | General |
| Category: INSOMNIA | ||||||
| 01/12/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: INSOMNIA | ||||||
| 01/05/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Inflammation | ||||||
| 12/29/2022 | Teva Pharmaceuticals USA, Inc. | ProAir Digihaler (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Respiratory | ||||||
| 12/01/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Immunology | ||||||
| 06/16/2022 | Teva Pharmaceuticals USA, Inc. | CINQAIR (Biological) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Respiratory | ||||||
| 03/25/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $115.18 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 09/26/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2018 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $120.07 | General |
| Category: Respiratory | ||||||
| 09/20/2018 | UCB, Inc. | Neupro (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Neurology | ||||||
| 08/08/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $104.94 | General |
| Category: Respiratory | ||||||
| 06/21/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Respiratory | ||||||
| 06/20/2018 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Respiratory | ||||||
| 05/29/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.85 | General |
| 05/02/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.72 | General |
| 04/16/2018 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/10/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Cardiovascular | ||||||
| 03/20/2018 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/12/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 411 | 470 | $131,026 | $27,911 |
| 2022 | 10 | 360 | 470 | $123,739 | $33,882 |
| 2021 | 12 | 489 | 648 | $151,692 | $47,543 |
| 2020 | 13 | 465 | 597 | $149,381 | $41,220 |
Total Patients
1,725
Total Services
2,185
Medicare Billing
$150,556
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 166 | 213 | $42,186 | $14,550 | 34.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 36 | 38 | $23,742 | $3,507 | 14.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $10,379 | $3,060 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 37 | $7,534 | $3,030 | 40.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 19 | 19 | $28,004 | $1,735 | 6.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2023 | 41 | 42 | $10,236 | $1,328 | 13.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 30 | 30 | $1,614 | $276.60 | 17.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 29 | 29 | $6,245 | $220.64 | 3.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 30 | 30 | $1,086 | $204.00 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 146 | 192 | $36,364 | $13,342 | 36.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 52 | $33,930 | $8,464 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 44 | $8,927 | $3,629 | 40.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 43 | $10,748 | $3,193 | 29.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 18 | 18 | $10,709 | $1,741 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $3,720 | $1,196 | 32.1% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 32 | 32 | $7,436 | $1,033 | 13.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 22 | $2,848 | $914.66 | 32.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 17 | 17 | $860.00 | $128.09 | 14.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 20 | 20 | $687.00 | $121.27 | 17.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 18 | 18 | $7,510 | $119.98 | 1.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 176 | 245 | $43,815 | $17,862 | 40.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 26 | 48 | $30,762 | $8,040 | 26.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 29 | 53 | $13,258 | $4,192 | 31.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 42 | $8,012 | $3,511 | 43.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 29 | $9,372 | $3,008 | 32.1% |
About Dr. Roger Boye, MD
Dr. Roger Boye, MD is a Internal Medicine healthcare provider based in Racine, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215039722.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Boye, MD has received a total of $1,595 in payments from pharmaceutical and medical device companies, with $158.68 received in 2023. These payments were reported across 79 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,550).
As a Medicare-enrolled provider, Boye has provided services to 1,725 Medicare beneficiaries, totaling 2,185 services with total Medicare billing of $150,556. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Racine, WI
- Active Since 09/04/2006
- Last Updated 12/06/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215039722
Products in Payments
- Prolastin-C (Biological) $214.68
- QUVIVIQ (Drug) $136.29
- FASENRA (Drug) $134.89
- UTIBRON (Drug) $126.53
- BEVESPI AEROSPHERE (Drug) $120.07
- XYWAV (Drug) $115.18
- Neupro (Drug) $106.11
- Air Mini (Device) $73.89
- NUCALA (Biological) $57.66
- ANORO (Drug) $56.74
- ELIQUIS (Drug) $35.66
- GLASSIA (Biological) $34.41
- CHANTIX (Drug) $30.06
- STIOLTO RESPIMAT (Drug) $26.79
- XOLAIR (Biological) $24.53
- TEZSPIRE (Biological) $22.39
- DUPIXENT (Biological) $19.58
- Multiple Products (Biological) $19.50
- AVYCAZ (Drug) $18.92
- CUBICIN RF (Drug) $17.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Racine
Kaye-Eileen Willard, Md, MD
Internal Medicine — Payments: $114,467
Internal Medicine $114,467
Gregory Culen, M.d, M.D
Internal Medicine — Payments: $5,142
Internal Medicine $5,142
Gerald Wisniewski, Md, MD
Internal Medicine — Payments: $4,673
Internal Medicine $4,673
Paul Durbin, M.d, M.D
Internal Medicine — Payments: $3,033
Internal Medicine $3,033
Dr. Michael Papp, D.o, D.O
Internal Medicine — Payments: $2,141
Internal Medicine $2,141
Joseph Mathew, M.d, M.D
Internal Medicine — Payments: $1,563
Internal Medicine $1,563